NUTRIMIND featured in Nutrition Insight
For the World Brain Day we spoke with Nutrition Insight to showcase NUTRIMIND’s objectives and developments. Below our insights from the conversation:
Overview of the NUTRIMIND project, and what new developments or capabilities it brings to nutrition and mental health research?
NUTRIMIND is a four-year Horizon Europe project exploring how diet, nutritional status, and the gut microbiome influence depression, anxiety, and other mental health outcomes throughout life. By integrating large-scale European data on nutrition, microbiome profiles, biomarkers, health, behavior, and socioeconomic factors, the project aims to overcome the fragmentation that has limited previous research.
NUTRIMIND combines nutrition, microbiome, biomarker and multi-omics data. Which types of nutritional ingredients or dietary patterns do you expect this approach to help validate most strongly?
NUTRIMIND is best suited to evaluating dietary patterns, combinations of foods (food groups) and nutrients, and broader nutritional profiles than to validating ingredients. The project will examine whether associations between mental health outcomes and particular dietary patterns, nutrient combinations, food groups or certain types of beverages (caffeine, alcohol, and sugar) are consistent across cohorts and supported by biological and behavioural data. Examples might include plant-rich or Mediterranean-style dietary patterns, overall diet quality based on – for example – vitamin and mineral content, or combinations of macro- and micronutrient exposures, depending on data available in the participating cohorts. An important strength will be that findings can be compared across age groups, countries, and population subgroups rather than being based on a single study. However, the project will assess the robustness and reproducibility of associations; it will not assume that a particular dietary pattern or nutrient is associated with mental health benefits without further evidence.
The project includes AI-supported modelling. How could AI help identify new ingredient combinations or consumer subgroups for personalized brain health and mental wellbeing products?
Under human oversight, AI can help detect complex patterns across biological and mental health data that would otherwise be too difficult and time-consuming to identify using conventional analyses alone. Using these tools might reveal combinations of dietary exposures and biological characteristics associated with different mental health outcomes. Models might also help identify population subgroups that share dietary, metabolic, or mental health profiles and assess whether associations differ by age, sex, socioeconomic circumstances, or other characteristics. This could improve our understanding of why similar dietary choices might not have the same impact for everyone. NUTRIMIND is not an ingredient-discovery or consumer-segmentation project, and its models will not produce personalised dietary recommendations or commercial product concepts. Instead, the main value will be in identify sources of variation, support the design of future targeted studies and interventions, and providing evidence to inform public health policy and prevention strategies.
Do you expect the project to identify microbiome signatures linked to mental health that could guide the development of next-generation probiotic, prebiotic or postbiotic ingredients?
NUTRIMIND will investigate whether reproducible microbiome features, microbial pathways or metabolite profiles are associated with depression, anxiety and other mental health outcomes. By harmonising microbiome and multi-omics data and analysing them alongside diet and clinical information, the project might identify microbiome signatures that warrant further investigation. A key question will be whether any associations are consistent across cohorts and remain robust after accounting for factors such as diet, age, and socioeconomic circumstances. The project is not developing specific probiotic, prebiotic or postbiotic ingredients. However, its findings could help identify microbial functions, metabolites or diet–microbiome interactions that merit follow-up in mechanistic studies and controlled interventions. Considerable additional work would still be needed before such findings could support development or substantiation of a specific ingredient.
Looking ahead, which findings from NUTRIMIND do you think could have the biggest impact on how nutrition companies develop and substantiate brain health products over the next five years?
The most important near-term contribution is likely to be stronger and more integrated evidence for which dietary patterns, nutrient combinations, biomarkers and microbiome features are consistently associated with particular mental health outcomes, and for whom. Reusable datasets, harmonised methods, and predictive models could help researchers better understand which dietary patterns, nutrient combinations and microbiome features are consistently associated with particular mental health outcomes. This evidence can improve the design of future intervention studies, support clearer and more targeted public health messaging for both physical and mental health, and help ensure that recommendations are based on robust and reproducible evidence for specifical population groups across their life course. NUTRIMIND findings might inform product innovation but will not provide evidence sufficient for product-specific health claims, which would still require appropriate product characterisation and controlled human studies demonstrating a cause-and-effect relationship.